Intervention

High altitude

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions5

Lead sponsors shown2

Clinical trials

2 shown

A Study on the Efficacy of Immunotherapy, the Occurrence and Severity of Adverse Reactions in Patients with Non-small Cell Lung Cancer in High-altitude AreasNCT06757114 · 2025-01-01

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High AltitudeNCT05063643 · 2021-10-01

Common conditions

Cardiac Toxicity1 HER2-positive Breast Cancer1 High Altitude1 Non-small Cell Lung Cancer(NSCLC)1 Targeted Therapy1

Leading sponsors

Affiliated Hospital of Qinghai University1 Second Affiliated Hospital of Xi'an Jiaotong University1

Trial status mix

UNKNOWN2

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.